Schedule 13D ownership disclosure
Can-Fite BioPharma Ltd.
Security class unavailable · CUSIP: 13471N201
Event date: 2019-10-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.7300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-19-002484
- Form type
- SC 13D
- Filer
- Can-Fite BioPharma Ltd.
- CIK
- CIK 1536196
- Filed
- Oct 17, 2019
- Reporting period
- Oct 07, 2019
- Description
- Schedule 13D beneficial ownership